n-Heptane hydroconversion over nickel-loaded aluminum- and/or boron-containing BEA zeolites prepared by recrystallization of magadiite varieties

Phase-pure [Al]BEA and [Al,B]BEA zeolites, prepared by solid-state recrystallization of synthetic aluminum-containing magadiites and conventionally synthesized [B]BEA, were tested, after ion exchange with nickel, as bifunctional catalysts for hydroconversion of n-heptane. The reducibility of nickel ions incorporated into BEA zeolites by ion exchange was investigated by temperature-programmed reduction (TPR). The acidity of the samples was characterized with strong (pyridine (Py), ammonia (NH3)) and weak (nitrogen) bases. The adsorbed bases were studied by transmission FT-IR (Py), diffuse reflectance infrared Fourier-transform (DRIFT) spectroscopy (N2), and temperature-programmed ammonia evolution (TPAE, NH3). Over Ni/H-[B]BEA the reactants were completely converted via fast hydrogenolysis, whereas this reaction pathway plays only a negligible role in the hydroconversion over Ni/H-[Al]BEA and Ni/H-[Al,B]BEA zeolites. Boron-containing BEA zeolites were less active catalysts than the boron-free catalyst in the principal unimolecular hydroconversion reactions. However, incorporation of boron into the framework of BEA zeolite results in a considerable selectivity shift towards isomerization. Results suggest that the acid strength of bridged hydroxyls, probed with weak (N2) and strong basis (pyridine), was found to be similar in the boron-free and boron-containing BEA samples. The decrease in the isomerization rate and the increase of the apparent activation energy upon incorporation of boron may be attributed to the decrease in the heat of n-heptane adsorption

Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)

In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0±15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and SjögrenD́s Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe. © 2012 Elsevier B.V